María Luisa Bravo describes the Spanish drug regulator’s development plans for the next three years.
This article examines the strategic plan of the Spanish Medicines and Healthcare Products Agency ( AEMPS) for 2009-2012 1. The 68-page plan, which was presented during the agency’s tenth anniversary celebration ceremony on 23 March, seeks to optimise the activities in which the AEMPS is involved and strengthen its role at the international level...
Please login to read the full article.
